
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex Inc. is positioned for strong revenue growth and margin expansion, driven by its interventional cardiology business following a competitor's market exit and bolstered by new product launches. The company is expected to maintain mid-single-digit organic growth, which, in conjunction with cost reduction efforts, may facilitate operating margin improvement and double-digit earnings growth. Further potential for enhancing earnings per share exists through debt repayment or share repurchases, indicating robust financial health and a promising outlook for shareholders.
Bears say
Teleflex Inc. has experienced lower-than-expected organic revenue and earnings per share (EPS) growth compared to its peers, which raises concerns about its competitive positioning and market performance. The company faces notable risks, including potential slower growth from key drivers, disappointing margin improvements, and the perceived risks associated with larger acquisitions that may dilute EPS. Furthermore, segments such as Interventional and Interventional Urology have shown weakness, notably in areas like the intra-aortic balloon pump, which could impede future revenue generation and overall financial health.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares